Mkt Cap$2.30T+1.08%
24h Vol$38.50B
BTC Dom56.4%
ETH Dom10.0%
F&G26Fear
BTC$64,767.00+0.93% ETH$1,918.48+2.72% USDT$0.9991+0.00% BNB$572.99+0.99% USDC$1.0.00% XRP$1.10+0.16% SOL$75.62+1.83% TRX$0.3326+0.57% FIGR_HELOC$1.03+1.64% HYPE$59.40+2.70% DOGE$0.0731+1.65% USDS$0.9999+0.00% RAIN$0.0141+0.58% LEO$9.72+0.24% ZEC$495.58+3.35% XMR$359.87-1.18% BTC$64,767.00+0.93% ETH$1,918.48+2.72% USDT$0.9991+0.00% BNB$572.99+0.99% USDC$1.0.00% XRP$1.10+0.16% SOL$75.62+1.83% TRX$0.3326+0.57% FIGR_HELOC$1.03+1.64% HYPE$59.40+2.70% DOGE$0.0731+1.65% USDS$0.9999+0.00% RAIN$0.0141+0.58% LEO$9.72+0.24% ZEC$495.58+3.35% XMR$359.87-1.18%
News

pain treatment

Total Stories
1
Section
pain treatment
Vertex Pharmaceuticals Stock Soars as its Non-Opiod Treatment for Pain Gets FDA Nod
Market Analysis

Vertex Pharmaceuticals Stock Soars as Non-Opioid Pain Treatment Gets FDA Nod

Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing acute pain.

Tim FriesJan 31, 20252 min read